{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:18:08Z","timestamp":1792113488133,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aase and Ejnar Danielsens Foundation"},{"name":"Foundation of Neurological research, Denmark"},{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["633491"],"award-info":[{"award-number":["633491"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.clinph.2017.11.015","type":"journal-article","created":{"date-parts":[[2017,11,26]],"date-time":"2017-11-26T16:01:00Z","timestamp":1511712060000},"page":"694-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivation"],"prefix":"10.1016","volume":"129","author":[{"given":"Rikke","family":"Heide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Bostock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Ventzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Grafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Bergmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Fuglsang-Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna B.","family":"Finnerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Tankisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2017.11.015_b0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(00)00667-1","article-title":"The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons","volume":"406","author":"Adelsberger","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinph.2017.11.015_b0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/cncr.27732","article-title":"Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer","volume":"119","author":"Argyriou","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.clinph.2017.11.015_b0015","series-title":"Handbook of clinical neurology","author":"Barnes","year":"2012"},{"key":"10.1016\/j.clinph.2017.11.015_b0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/0284186X.2014.980912","article-title":"Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry","volume":"54","author":"Beijers","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clinph.2017.11.015_b0025","first-page":"1999","article-title":"A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration","volume":"22","author":"Beijers","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clinph.2017.11.015_b0030","unstructured":"Bergmans J. The physiology of single human nerve fibres. Vander: University of Louvain; 1970."},{"key":"10.1016\/j.clinph.2017.11.015_b0035","doi-asserted-by":"crossref","first-page":"e98262","DOI":"10.1371\/journal.pone.0098262","article-title":"Potassium and the excitability properties of normal human motor axons in vivo","volume":"9","author":"Boerio","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clinph.2017.11.015_b0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C","article-title":"Threshold tracking techniques in the study of human peripheral nerve","volume":"21","author":"Bostock","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2017.11.015_b0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","article-title":"Development and validation of the Neuropathic Pain Symptom Inventory","volume":"108","author":"Bouhassira","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.clinph.2017.11.015_b0050","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.090034797","article-title":"Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses","volume":"97","author":"Caldwell","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinph.2017.11.015_b0055","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1661::AID-MUS6>3.0.CO;2-N","article-title":"Ectopic impulse generation and autoexcitation in single myelinated afferent fibers in patients with peripheral neuropathy and positive sensory symptoms","volume":"21","author":"Campero","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2017.11.015_b0060","unstructured":"DCCG. Danish Colorectal Cancer Group. Retningslinjer for diagnostik og behandling af kolorektalkr\u00e6ft. Danish Colorectal Cancer Group; 2015."},{"key":"10.1016\/j.clinph.2017.11.015_b0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1385\/MO:19:4:261","article-title":"Pharmacokinetics of oxaliplatin in humans","volume":"19","author":"Ehrsson","year":"2002","journal-title":"Medical Oncol"},{"key":"10.1016\/j.clinph.2017.11.015_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/sonc.2002.35525","article-title":"Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures","volume":"29","author":"Gamelin","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clinph.2017.11.015_b9000","first-page":"27","article-title":"Molecular Biology and Clinical Mitigation of Cancer Treatment-Induced Neuropathy","author":"Higa","year":"2016","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.clinph.2017.11.015_b0075","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1113\/jphysiol.2011.225573","article-title":"The voltage dependence of I(h) in human myelinated axons","volume":"590","author":"Howells","year":"2012","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2017.11.015_b0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/1871520611313020023","article-title":"Oxaliplatin-induced hyperexcitation of rat sciatic nerve fibres: an intra-axonal study","volume":"13","author":"Kagiava","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.clinph.2017.11.015_b0085","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.neuro.2008.09.005","article-title":"The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat","volume":"29","author":"Kagiava","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.clinph.2017.11.015_b0090","first-page":"761","article-title":"Oxaliplatin pharmacokinetics during a four-hour infusion","volume":"5","author":"Kern","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"Pt 12","key":"10.1016\/j.clinph.2017.11.015_b0095","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/brain\/123.12.2542","article-title":"Effects of membrane polarization and ischaemia on the excitability properties of human motor axons","volume":"123","author":"Kiernan","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2017.11.015_b9010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.70.1.56","article-title":"Excitability properties of motor axons in patients with spontaneous motor activity","author":"Kiernan","year":"2001","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1016\/j.clinph.2017.11.015_b0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.20395","article-title":"Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish","volume":"57","author":"Kiernan","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinph.2017.11.015_b0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-444-52902-2.00004-7","article-title":"Physiology and pathophysiology of myelinated nerve fibers","volume":"115","author":"Kiernan","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.clinph.2017.11.015_b0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mus.20340","article-title":"Oxaliplatin-induced neurotoxicity and the development of neuropathy","volume":"32","author":"Krishnan","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2017.11.015_b0115","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1158\/1078-0432.CCR-06-0694","article-title":"Oxaliplatin and axonal Na+ channel function in vivo","volume":"12","author":"Krishnan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinph.2017.11.015_b0120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.pneurobio.2009.08.002","article-title":"Axonal ion channels from bench to bedside: a translational neuroscience perspective","volume":"89","author":"Krishnan","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.clinph.2017.11.015_b0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1469-7793.2001.0265j.x","article-title":"Voluntary contraction impairs the refractory period of transmission in healthy human axons","volume":"531","author":"Kuwabara","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2017.11.015_b0130","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2006.08.6652","article-title":"Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07","volume":"25","author":"Land","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinph.2017.11.015_b0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mus.10559","article-title":"Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy","volume":"29","author":"Lehky","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clinph.2017.11.015_b9015","article-title":"Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer","volume":"116","author":"Leonard","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clinph.2017.11.015_b0140","first-page":"782","article-title":"Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin","volume":"21","author":"McHugh","year":"2012","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.clinph.2017.11.015_b0145","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","article-title":"Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry","volume":"31","author":"Mols","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinph.2017.11.015_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0731-7085(00)00377-0","article-title":"Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin","volume":"24","author":"Morrison","year":"2000","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.clinph.2017.11.015_b0155","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1200\/JCO.2014.58.8533","article-title":"Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III Trial N08CB (Alliance)","volume":"33","author":"Pachman","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinph.2017.11.015_b0160","first-page":"2281","article-title":"Management options for established chemotherapy-induced peripheral neuropathy","volume":"22","author":"Pachman","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clinph.2017.11.015_b0165","first-page":"419","article-title":"Chemotherapy-induced peripheral neurotoxicity: a critical analysis","volume":"63","author":"Park","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clinph.2017.11.015_b0170","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1200\/JCO.2008.19.3425","article-title":"Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity","volume":"27","author":"Park","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinph.2017.11.015_b0175","doi-asserted-by":"crossref","unstructured":"Park SB, Lin CS, Kiernan MC. Nerve excitability assessment in chemotherapy-induced neurotoxicity. J Vis Exp 2012;62. https:\/\/doi.org\/10.3791\/439.","DOI":"10.3791\/3439"},{"key":"10.1016\/j.clinph.2017.11.015_b0180","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/brain\/awp219","article-title":"Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy","volume":"132","author":"Park","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2017.11.015_b0185","doi-asserted-by":"crossref","first-page":"e18469","DOI":"10.1371\/journal.pone.0018469","article-title":"Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity","volume":"6","author":"Park","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clinph.2017.11.015_b0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.pain.2006.01.041","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values","volume":"123","author":"Rolke","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.clinph.2017.11.015_b0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpain.2005.02.003","article-title":"Quantitative sensory testing: a comprehensive protocol for clinical trials","volume":"10","author":"Rolke","year":"2006","journal-title":"Eur J Pain"},{"key":"10.1016\/j.clinph.2017.11.015_b0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1113\/jphysiol.2006.106815","article-title":"KCNQ channels mediate the slow K+ current in the rat node of Ranvier","volume":"573","author":"Schwarz","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2017.11.015_b0205","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neuro.2010.07.006","article-title":"Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy","volume":"31","author":"Sittl","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.clinph.2017.11.015_b0210","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1073\/pnas.1118058109","article-title":"Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current","volume":"109","author":"Sittl","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinph.2017.11.015_b0215","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuro.2006.04.010","article-title":"Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding","volume":"27","author":"Ta","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.clinph.2017.11.015_b0220","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/j.pain.0000000000000404","article-title":"Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel","volume":"157","author":"Ventzel","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.clinph.2017.11.015_b0225","doi-asserted-by":"crossref","unstructured":"Ventzel L, Madsen CS, Jensen AB, Jensen AR, Jensen TS, Finnerup NB. Assessment of acute oxaliplatin-induced cold allodynia: a pilot study. Acta Neurol Scand. 2015. https:\/\/doi.org\/10.1111\/ane.12443.","DOI":"10.1111\/ane.12443"},{"key":"10.1016\/j.clinph.2017.11.015_b0230","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2002.07.056","article-title":"Acute oxaliplatin-induced peripheral nerve hyperexcitability","volume":"20","author":"Wilson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinph.2017.11.015_b0235","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1523\/JNEUROSCI.1628-04.2004","article-title":"Fibroblast growth factor homologous factor 2B: association with Nav1.6 and selective colocalization at nodes of Ranvier of dorsal root axons","volume":"24","author":"Wittmack","year":"2004","journal-title":"J Neurosci"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245717311628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245717311628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:43:34Z","timestamp":1761392614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245717311628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1388245717311628"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2017.11.015","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivation","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2017.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}